Medicine and Dentistry
Hodgkin's Lymphoma
100%
ABVD
42%
International Prognostic Index
40%
Positron Emission Tomography
36%
Polyethylene Terephthalate
28%
Progression Free Survival
28%
Diffuse Large B-Cell Lymphoma
26%
Microangiopathy
26%
Cyclophosphamide
26%
Risk Stratification
25%
Drug Megadose
24%
Dacarbazine
23%
Diseases
22%
Thrombotic Thrombocytopenic Purpura
22%
Mutational Analysis
22%
Stem Cell Transplant
20%
Adult T-Cell Leukemia/Lymphoma
20%
Burkitt's Lymphoma
20%
Allergic Response
20%
Atypical Hemolytic Uremic Syndrome
20%
Myeloma
20%
Carfilzomib
20%
Autologous Hematopoietic Stem Cell Transplantation
20%
COVID-19 Vaccine
20%
Von Willebrand Factor Cleaving Proteinase
20%
Dexamethasone
20%
Observational Study
20%
Procarbazine
20%
BEACOPP
20%
Neoplasm
20%
Revaccination
16%
Excipient
16%
Survival Rate
14%
Hematopoietic Cell
13%
Classical Hodgkin Lymphoma
12%
Doxorubicin
12%
Central Nervous System
10%
Methotrexate
10%
Metabolism
10%
Induction Chemotherapy
10%
Survival Estimate
10%
Overall Survival
9%
Stem Cell
8%
Proportional Hazards Model
8%
Vinblastine
8%
Bleomycin
8%
mRNA Vaccine
8%
Lymphoma
6%
Clinical Management
6%
Chemoradiotherapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
39%
Progression Free Survival
39%
Diffuse Large B Cell Lymphoma
26%
Rituximab
24%
Vaccination Policy
20%
Burkitt's Lymphoma
20%
Obinutuzumab
20%
Thrombotic Thrombocytopenic Purpura
20%
Follicular Lymphoma
20%
COVID-19 Vaccine
20%
Disease
20%
Survival Rate
14%
Allergic Reaction
14%
Excipient
11%
Methotrexate
10%
Overall Survival
10%
Adverse Event
9%
Lymphocyte Membrane Immunoglobulin
8%
Lactate Dehydrogenase
6%
First-Line Chemotherapy
6%
Long Term Survival
6%
Lymphoma
6%
Disease Course
6%
Chemotherapy Regimens
6%
Monoclonal Antibody
6%
HIV
6%
mRNA Vaccine
5%
Immunology and Microbiology
B Cell
20%
Leukemia Cell
20%
Thrombotic Thrombocytopenic Purpura
20%
Lymph Node
20%
Positron Emission Tomography
20%
Event Free Survival
20%
Progression Free Survival
12%
Drug Megadose
8%
Survival Rate
8%